MYD88 somatic mutations in MALT lymphomas-Reference-Cited by-同舟云学术

MYD88 somatic mutations in MALT lymphomas

Published:2012-05-29 Issue:5 Volume:158 Page:662-664
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Li Zhi-Ming,Rinaldi Andrea¹,Cavalli Andrea²,Mensah Afua A.¹,Ponzoni Maurilio³,Gascoyne Randy D.⁴,Bhagat Govind⁵,Zucca Emanuele⁶,Bertoni Francesco

Affiliation:

1. IOR-Institute of Oncology Research; Bellinzona; Switzerland

2. Department of Chemistry; University of Cambridge; Cambridge; UK

3. Unit of Lymphoid Malignancies; Department of Onco-Haematology; San Raffaele Scientific Institute; Milan; Italy

4. Department of Pathology; British Columbia Cancer Agency; Vancouver; BC; Canada

5. Herbert Irving Comprehensive Cancer Center; Department of Pathology and Cell Biology; Columbia University Medical Center and New York Presbyterian Hospital; New York; NY; USA

6. IOSI-Oncology Institute of Southern Switzerland; Bellinzona; Switzerland

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2012.09176.x/fullpdf

Reference10 articles.

1. MALT lymphomas: pathogenesis can drive treatment;Bertoni;Oncology (Williston Park),2011

2. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation;Fabbri;Journal of Experimental Medicine,2011

3. Interactive sites in the MyD88 Toll/Interleukin (IL) 1 receptor domain responsible for coupling to the IL1β signaling pathway;Li;Journal of Biological Chemistry,2005

4. Absence of NOTCH1 gene mutations in MALT lymphomas;Mensah;British Journal of Haematology,2012

5. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma;Morin;Nature,2011

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the frequency of somatic MYD88 L265P mutation in primary ocular adnexal B cell lymphoma;Molecular Biology Reports;2024-09-09

2. IRAK-4 inhibition: emavusertib for the treatment of lymphoid and myeloid malignancies;Frontiers in Immunology;2023-10-26

3. Aggressive Lymphoplasmacytic Neoplasm With an Unusual In-frame Deletion of MYD88 Associated With TRAF3 and TP53 Mutations and Complex Karyotype;International Journal of Surgical Pathology;2023-04-24

4. Targeting IRAK4 with Emavusertib in Lymphoma Models with Secondary Resistance to PI3K and BTK Inhibitors;Journal of Clinical Medicine;2023-01-04

5. Hematolymphoid Tumors of the Sinonasal Tract;Atlas of Sinonasal Tract Pathology;2023